GENE ONLINE|News &
Opinion
Blog

Red Blood Cell
China Rare Disease
China’s CANbridge Reports Positive Phase 1 Data of Contender to AstraZeneca’s Complement Inhibitor
2022-02-08
Trials & Approvals Sanofi
Sanofi’ Enjaymo Wins FDA Approval for Rare Autoimmune Anemia
2022-02-07
Trials & Approvals Sickle Cell Disease
Imara’s Sickle Cell Disease Therapy Impresses in Phase 2 Trial
2021-01-09
Funding I-Mab
Abbvie Places $2 Billion Bet on Flourishing Immunotherapy Area with this Oncology Partnership
2020-09-06
Trials & Approvals CRISPR
CRISPR, Vertex’s Gene Editing Based Therapy, CTX001 Prospers in Hemoglobinopathy Trials
2020-06-18
R&D Acute Myeloid Leukemia
Gilteritinib becomes first FLT3 targeted therapy for relapsed AML
2018-12-04
LATEST
Forced Migrants in Ukraine Face Barriers to HIV and TB Care Amid Disrupted Healthcare Systems
2026-01-23
Residual Cardiovascular Risk Persists in Coronary Artery Disease Despite Advances in Treatment
2026-01-23
Advocacy-Informed Research and PRISM Framework Highlighted in Healthcare Policy Reform Strategies
2026-01-23
Study Explores Link Between Red Blood Cell Distribution Width and Prognosis in Peripheral T-Cell Lymphoma
2026-01-23
Study Finds Jackdaw Contact Calls Exhibit Individual Variability for Social Communication
2026-01-23
Study Analyzes Measles Infection Trends Among Children in Togo from 2020 to 2024
2026-01-23
Study in Thailand Finds Higher Osteoporosis Rates Among Type 2 Diabetes Patients
2026-01-23
READ MORE
EVENT
2026-02-09
World Health Expo Dubai
Dubai Exhibition Centre, Dubai
2026-02-17
BIO Asia 2026 (Life Science Partnerships)
Hyderabad, India
2026-02-24
Rare Disease Week on Capitol Hill (Policy and Advocacy)
Capitol Hill, Washington, D.C.
2026-03-09
HIMSS26 (Digital Health & Hospital IT)
Las Vegas, Nevada
2026-03-10
Bioprocessing Summit Europe (Biomanufacturing Trends)
Barcelona, Spain
2026-03-23
DCAT Week
New York, USA
SEE MORE
Scroll to Top